HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angiogenesis and cardioprotection after TNFalpha-inducer-Tolpa Peat Preparation treatment in rat's hearts after experimental myocardial infarction in vivo.

Abstract
The aim of the presented work was to evaluate whether short subcutaneous (s.c.) administration of TNFalpha-inducer-Tolpa Peat Preparation (TPP or TPP batch 0210) modulates the process of ischemic remodeling and spontaneous angiogenesis after experimental myocardial infarction (MI) in rats in vivo. The results obtained using three complementary and correlative methods: histological studies, Proliferating Cell Nuclear Antigen (PCNA) reaction and Lymphocytes Induced Angiogenesis (LIA) test showed a clear pro-angiogenic and cardioprotective effect of TPP administration after experimental MI. TPP batch 0210 should be considered as an angiogenesis stimulating factor and consecutively as a cardioprotective preventing development of ischemic cardiomyopathy after MI in rats. It might possibly be used as an adjunct to conventional therapy of coronary artery disease, including late phase after myocardial infarction or ischemic cardiomyopathy.
AuthorsTadeusz F Krzemiński, Jerzy K Nozyński, Joanna Grzyb, Maurycy Porc, Sławomir Zegleń, Violetta Filas, Ewa Skopińska-Rózewska, Ewa Sommer, Małgorzata Filewska
JournalVascular pharmacology (Vascul Pharmacol) Vol. 43 Issue 3 Pg. 164-70 (Sep 2005) ISSN: 1537-1891 [Print] United States
PMID16043419 (Publication Type: Journal Article)
Chemical References
  • Amino Acids
  • Carbohydrates
  • Cardiotonic Agents
  • Drug Combinations
  • Humic Substances
  • Tolpa
  • Tumor Necrosis Factor-alpha
  • Uronic Acids
Topics
  • Amino Acids (administration & dosage, pharmacology, therapeutic use)
  • Animals
  • Carbohydrates (administration & dosage, pharmacology, therapeutic use)
  • Cardiotonic Agents (administration & dosage, pharmacology, therapeutic use)
  • Disease Models, Animal
  • Drug Combinations
  • Humic Substances
  • Immunohistochemistry
  • Injections, Subcutaneous
  • Male
  • Myocardial Infarction (drug therapy, metabolism, pathology)
  • Myocardium (metabolism, pathology)
  • Neovascularization, Physiologic (drug effects)
  • Rats
  • Rats, Sprague-Dawley
  • Tumor Necrosis Factor-alpha (biosynthesis)
  • Uronic Acids (administration & dosage, pharmacology, therapeutic use)
  • Ventricular Remodeling (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: